Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy

Restricted access

✓ This prospective randomized clinical trial compared the effectiveness of combined treatment with CCNU and radiation therapy to the use of radiation therapy alone for the postoperative management of supratentorial brain gliomas (67% anaplastic) in 198 patients. The results were evaluated with the aid of a specially developed weighted neuropsychological test battery providing single-value estimation of “life quality” of patients, as well as with a clinical performance scale. Based on these methods, it was established that patients improved within 6 months following therapy. This improvement was maintained in surviving patients during the 2-year follow-up period. The patients led a relatively normal life, but when their condition deteriorated their decline was rapid. The median survival time of patients treated with radiotherapy did not differ significantly from that of patients receiving chemotherapy in addition. Nor did the analysis of life quality and of changes in clinical performance show any benefit in supplementing surgery and radiation therapy with CCNU chemotherapy at the dosage used.

Article Information

Address reprint requests to: Tomasz Trojanowski, M.D., Department of Neurosurgery, Ogrodowa 15/3, 20-075 Lublin, Poland.

© AANS, except where prohibited by US copyright law.

Headings

Figures

References

  • 1.

    Áfra DKocsis BDobay Jet al: Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 59:1061101983Áfra D Kocsis B Dobay J et al: Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas. J Neurosurg 59:106–110 1983

    • Search Google Scholar
    • Export Citation
  • 2.

    Chang CHHorton JSchoenfeld Det al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:99710071983Chang CH Horton J Schoenfeld D et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997–1007 1983

    • Search Google Scholar
    • Export Citation
  • 3.

    Coldman AJElwood JM: Examining survival data. Can Med Assoc J 121:106510711979Coldman AJ Elwood JM: Examining survival data. Can Med Assoc J 121:1065–1071 1979

    • Search Google Scholar
    • Export Citation
  • 4.

    Edwards MSLevin VAWilson CB: Brain tumor chemotherapy: an evaluation of agents in current use for Phase II and III trials. Cancer Treat Rep 64:117912051980Edwards MS Levin VA Wilson CB: Brain tumor chemotherapy: an evaluation of agents in current use for Phase II and III trials. Cancer Treat Rep 64:1179–1205 1980

    • Search Google Scholar
    • Export Citation
  • 5.

    EORTC Brain Tumor Group: Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma — final evaluation. Eur J Cancer 14:8518561978EORTC Brain Tumor Group: Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma — final evaluation. Eur J Cancer 14:851–856 1978

    • Search Google Scholar
    • Export Citation
  • 6.

    EORTC Brain Tumor Group: Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma — first evaluation. Eur J Cancer 12:41451976EORTC Brain Tumor Group: Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma — first evaluation. Eur J Cancer 12:41–45 1976

    • Search Google Scholar
    • Export Citation
  • 7.

    EORTC Brain Tumor Group: Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J Neurosurg 55:27311981EORTC Brain Tumor Group: Evaluation of CCNU VM-26 plus CCNU and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J Neurosurg 55:27–31 1981

    • Search Google Scholar
    • Export Citation
  • 8.

    Gibberd FBScott GM: Morbidity in patients with intracranial gliomas. J Neurol Neurosurg Psychiatry 46:4601983 (Letter)Gibberd FB Scott GM: Morbidity in patients with intracranial gliomas. J Neurol Neurosurg Psychiatry 46:460 1983 (Letter)

    • Search Google Scholar
    • Export Citation
  • 9.

    Greenberg HSEnsminger WDChandler WFet al: Intraarterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 61:4234291984Greenberg HS Ensminger WD Chandler WF et al: Intraarterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 61:423–429 1984

    • Search Google Scholar
    • Export Citation
  • 10.

    Gullotta F: Morphological and biological basis for the classification of brain tumors. With a comment on the WHO-classification 1979. Adv Tech Stand Neurosurg 8:1231651981Gullotta F: Morphological and biological basis for the classification of brain tumors. With a comment on the WHO-classification 1979. Adv Tech Stand Neurosurg 8:123–165 1981

    • Search Google Scholar
    • Export Citation
  • 11.

    Hansen HHMuggia FM: Treatment of malignant brain tumors with nitrosoureas. Cancer Chemother Rep 55:991001971 (Letter)Hansen HH Muggia FM: Treatment of malignant brain tumors with nitrosoureas. Cancer Chemother Rep 55:99–100 1971 (Letter)

    • Search Google Scholar
    • Export Citation
  • 12.

    Kaplan ELMeier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:4574811958Kaplan EL Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481 1958

    • Search Google Scholar
    • Export Citation
  • 13.

    Laws ER JrTaylor WFClifton MBet al: Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:6656731984Laws ER Jr Taylor WF Clifton MB et al: Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:665–673 1984

    • Search Google Scholar
    • Export Citation
  • 14.

    Levin VACrafts DCNorman DMet al: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47:3293351977Levin VA Crafts DC Norman DM et al: Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg 47:329–335 1977

    • Search Google Scholar
    • Export Citation
  • 15.

    Levin VAWilson CBDavis Ret al: A Phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J Neurosurg 51:5265321979Levin VA Wilson CB Davis R et al: A Phase III comparison of BCNU hydroxyurea and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas. J Neurosurg 51:526–532 1979

    • Search Google Scholar
    • Export Citation
  • 16.

    Reagan TJBisel FChilds DS Jret al: Controlled study of CCNU and radiation therapy in malignant astrocytoma. J Neurosurg 44:1861901976Reagan TJ Bisel F Childs DS Jr et al: Controlled study of CCNU and radiation therapy in malignant astrocytoma. J Neurosurg 44:186–190 1976

    • Search Google Scholar
    • Export Citation
  • 17.

    Rosenblum MLReynolds AF JrSmith KAet al: Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J Neurosurg 39:3063141973Rosenblum ML Reynolds AF Jr Smith KA et al: Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors. J Neurosurg 39:306–314 1973

    • Search Google Scholar
    • Export Citation
  • 18.

    Seiler RWGreiner RHZimmerman Aet al: Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas. J Neurosurg 48:8618651978Seiler RW Greiner RH Zimmerman A et al: Radiotherapy combined with procarbazine bleomycin and CCNU in the treatment of high-grade supratentorial astrocytomas. J Neurosurg 48:861–865 1978

    • Search Google Scholar
    • Export Citation
  • 19.

    Skołyszewski J: Radioterapia nowotworów ośrodkowego układu nerwowego. Instytutu Fizyki Jądrowej Raport No. 1090. Crakow, Poland: IFJ1980Skołyszewski J: Radioterapia nowotworów ośrodkowego układu nerwowego. Instytutu Fizyki Jądrowej Raport No. 1090. Crakow Poland: IFJ 1980

    • Search Google Scholar
    • Export Citation
  • 20.

    Walker MDAlexander E JrHunt WEet al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:3333431978Walker MD Alexander E Jr Hunt WE et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49:333–343 1978

    • Search Google Scholar
    • Export Citation
  • 21.

    Walker MDGreen SBByar DPet al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:132313291980Walker MD Green SB Byar DP et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323–1329 1980

    • Search Google Scholar
    • Export Citation
  • 22.

    Wara WM: Radiation therapy for brain tumors. Cancer 55:229122951985Wara WM: Radiation therapy for brain tumors. Cancer 55:2291–2295 1985

    • Search Google Scholar
    • Export Citation
  • 23.

    Wilson CB: Brain tumors. N Engl J Med 300:146914711979Wilson CB: Brain tumors. N Engl J Med 300:1469–1471 1979

  • 24.

    Wilson CBGutin PBoldrey EBet al: Single-agent chemotherapy of brain tumors. A five-year review. Arch Neurol 33:7397441976Wilson CB Gutin P Boldrey EB et al: Single-agent chemotherapy of brain tumors. A five-year review. Arch Neurol 33:739–744 1976

    • Search Google Scholar
    • Export Citation
  • 25.

    Yamamoto YLDiksic MSako Ket al: Pharmacokinetic and metabolic studies in human malignant glioma in Magistretti PL (ed): Functional Radionuclide Imaging of the Brain. New York: Raven Press1983 pp 327335Yamamoto YL Diksic M Sako K et al: Pharmacokinetic and metabolic studies in human malignant glioma in Magistretti PL (ed): Functional Radionuclide Imaging of the Brain. New York: Raven Press 1983 pp 327–335

    • Search Google Scholar
    • Export Citation
  • 26.

    Zülch KJ: Histological Typing of Tumours of the Central Nervous System. International Histological Classification of Tumours No. 21. Geneva: World Health Organization1979Zülch KJ: Histological Typing of Tumours of the Central Nervous System. International Histological Classification of Tumours No. 21. Geneva: World Health Organization 1979

    • Search Google Scholar
    • Export Citation

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 37 37 7
Full Text Views 120 120 0
PDF Downloads 80 80 0
EPUB Downloads 0 0 0

PubMed

Google Scholar